1. Adderson EE. Histoplasmosis in a pediatric oncology center. J Pediatr. Jan 2004; 144(1):100-106. Available at http://www.ncbi.nlm.nih.gov/pubmed/14722526.
2. Agwu AL, Fairlie L. Antiretroviral treatment, management challenges and outcomes in perinatal HIV-infected adolescents. J Int AIDS Soc. 2013;16:18579. Available at http://www.ncbi.nlm.nih.gov/pubmed/23782477.
3. Akolo C et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database of Systematic Reviews, 2010, (1): CD000171.
4. Antiretroviral therapy for HIV infection in adults and adolescents: towards universal access. Recommendations for a public health approach. 2010 revision. Geneva, World Health Organization, 2010. (На русском языке: Антиретровирусная терапия ВИЧ-инфекции у взрослых и подростков. Рекомендации с позиций общественного здравоохранения. Пересмотренное издание 2010. Женева, Всемирная организация здравоохранения, 2010. (По состоянию на 05.05.2012 г.).
5. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. Feb 2011; 49(2):665-670. Available at http://www.ncbi.nlm.nih.gov/pubmed/21106797.
6. Balfour HH, Jr., Benson C, Braun J, et al. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr.Mar 1994;7(3):254-260. Available at http://www.ncbi.nlm.nih.gov/pubmed/8106965.
7. Benhamou Y, Thibault V, Vig P, et al. Safety and efficacy of adefovir dipivoxil in patients infected with lamivudineresistant hepatitis B and HIV-1. J Hepatol. Jan 2006;44(1):62-67.
8. Benson CA, Williams PL, Cohn DL, et al. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. J Infect Dis. Apr 2000;181(4):1289-1297. Available at http://www.ncbi.nlm.nih.gov/pubmed/10762562
9. Benson CA, Williams PL, Currier JS, et al. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis. Nov 1 2003;37(9):1234-1243. Available at http://www.ncbi.nlm.nih.gov/pubmed/14557969.
10. Blyth CC, Palasanthiran P, O'Brien TA. Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics. Apr 2007;119(4):772-784. Available at http://www.ncbi.nlm.nih.gov/pubmed/17403849.
11. Bortolotti F, Calzia R, Cadrobbi P, et al. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood.J Pediatr. Feb 1986;108(2):224-227.
12. Bortolotti F, Guido M, Bartolacci S, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology. Mar 2006;43(3):556-562.
13. Brooks JT, Song R, Hanson DL, et al. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002. Clin Infect Dis. Aug 15 2005;41(4):549-553. Available athttp://www.ncbi.nlm.nih.gov/pubmed/16028167.
14. Burack G, Gaur S, Marone R, Petrova A. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1). J Pediatr Nurs. 2010;25(6):500-504. Available at http://www.ncbi.nlm.nih.gov/pubmed/21035017.
15. Burgard M, Blanche S, Jasseron C, et al. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. J Pediatr. 2012;160(1):60-66 e61.
16. Cagle HH, Jacob J, Homan CE, Williams JL, Christensen CJ, McMahon BJ. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992. Arch Pediatr Adolesc Med. Feb 2007;161(2):125-130.
17. Calitri C, Gabiano C, Galli L, et al. The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for pediatric HIV infection. BMC Infect Dis. 2014;14:277. Available at http://www.ncbi.nlm.nih.gov/pubmed/24885649.
18. CDC. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention. MMWR Recomm Rep. Apr 28 1995;44 (RR-4):1-11.
19. CDC. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR Recomm Rep. Mar 15 1991;40(RR-2):1-13.
20. Centers for Disease Control and Prevention. HIV surveillance report; vol 26. 2014. Available at http://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv- surveillance-report-us.pdf.
21. Chan C, Montaner J, Lefebvre EA, et al. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. J Infect Dis. Aug 1999;180(2):369-376.
22. Chan SP, Birnbaum J, Rao M, Steiner P. Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J. May 1996;15(5):443-447. Available at http://www.ncbi.nlm.nih.gov/pubmed/8724068.
23. Chandwani S, Kaul A, Bebenroth D, et al. Cytomegalovirus infection in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. Apr 1996;15(4):310-314. Available at http://www.ncbi.nlm.nih.gov/pubmed/8866799.